Investor Presentaiton slide image

Investor Presentaiton

Consolidated Statement of Profit or Loss (RMB 000s) Revenue Cost of services Gross profit Other income Other gains and losses, net Impairment losses Selling and marketing expenses Administrative expenses Research and development expenses Share of losses of associates Finance costs Profit before tax Income tax expense Profit for the year Profit attributable to owners of the Company Adjusted for: Share-based compensation expense Net foreign Exchange loss/(gain) Year ended June 30, 2022 3,594,209 (2,175,881) 2023 3,710,850 (2,244,568) 1,418,328 1,466,282 128,757 147,146 468,609 571,836 (28,411) (29,777) (80,040) (88,998) (321,379) (350,171) (110,520) (128,082) 35,556 63,724 (31,035) (52,815) 1,479,865 1,599,145 (162,239) (191,055) 1,317,626 1,408,090 1,192,004 1,388,337 16,673 (1,829) 48,476 (17,659) Amortization of intangible assets arising from acquisitions 17,225 Change in fair value of financial assets at FVTPL (347,542) Adjusted net profit attributable to owners of the Company(1) 876,531 5,472 (529,013) 895,613 ●Tigermed (1) Non-IFRS measure 28
View entire presentation